164 related articles for article (PubMed ID: 11747902)
1. Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523.
Tottori K; Miwa T; Uwahodo Y; Yamada S; Nakai M; Oshiro Y; Kikuchi T; Altar CA
Neuropharmacology; 2001 Dec; 41(8):976-88. PubMed ID: 11747902
[TBL] [Abstract][Full Text] [Related]
2. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
Bermack JE; Haddjeri N; Debonnel G
J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA
J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
Tordera RM; Monge A; Del Río J; Lasheras B
Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
[TBL] [Abstract][Full Text] [Related]
5. Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors.
Bermack JE; Debonnel G
J Psychopharmacol; 2007 Jan; 21(1):85-92. PubMed ID: 16533864
[TBL] [Abstract][Full Text] [Related]
6. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like effect of combined treatment with selective sigma receptor agonists and a 5-HT1A receptor agonist in the forced swimming test in rats.
Skuza G; Rogóz Z
Pharmacol Rep; 2007; 59(6):773-7. PubMed ID: 18195469
[TBL] [Abstract][Full Text] [Related]
8. PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects.
Corbin AE; Meltzer LT; Ninteman FW; Wiley JN; Christoffersen CL; Wustrow DJ; Wise LD; Pugsley TA; Heffner TG
Neuropharmacology; 2000 Apr; 39(7):1211-21. PubMed ID: 10760363
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
Rogóz Z; Skuza G
Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
[TBL] [Abstract][Full Text] [Related]
10. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
[TBL] [Abstract][Full Text] [Related]
11. The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.
Pytka K; Walczak M; Kij A; Rapacz A; Siwek A; Kazek G; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B
Eur J Pharmacol; 2015 Oct; 764():537-546. PubMed ID: 26210317
[TBL] [Abstract][Full Text] [Related]
12. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
[TBL] [Abstract][Full Text] [Related]
13. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.
Jordan S; Koprivica V; Chen R; Tottori K; Kikuchi T; Altar CA
Eur J Pharmacol; 2002 Apr; 441(3):137-40. PubMed ID: 12063084
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.
Bourin M; Mocaër E; Porsolt R
J Psychiatry Neurosci; 2004 Mar; 29(2):126-33. PubMed ID: 15069466
[TBL] [Abstract][Full Text] [Related]
15. Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test.
Estrada-Camarena E; Fernández-Guasti A; López-Rubalcava C
Neuropsychopharmacology; 2006 Feb; 31(2):247-55. PubMed ID: 16012533
[TBL] [Abstract][Full Text] [Related]
16. Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test.
Miyata S; Hirano S; Kamei J
Neuropsychopharmacology; 2004 Mar; 29(3):461-9. PubMed ID: 14628002
[TBL] [Abstract][Full Text] [Related]
17. Modulation of serotonergic function in rat brain by VN2222, a serotonin reuptake inhibitor and 5-HT1A receptor agonist.
Romero L; Celada P; Martín-Ruiz R; Díaz-Mataix L; Mourelle M; Delgadillo J; Hervás I; Artigas F
Neuropsychopharmacology; 2003 Mar; 28(3):445-56. PubMed ID: 12629524
[TBL] [Abstract][Full Text] [Related]
18. A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test.
Gigliucci V; Buckley KN; Nunan J; O'Shea K; Harkin A
Pharmacol Biochem Behav; 2010 Feb; 94(4):524-33. PubMed ID: 19945477
[TBL] [Abstract][Full Text] [Related]
19. Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice.
Clenet F; De Vos A; Bourin M
Eur Neuropsychopharmacol; 2001 Apr; 11(2):145-52. PubMed ID: 11313160
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antidepressant activity of a series of arylalkanol and aralkyl piperazine derivatives targeting SSRI/5-HT
Gu ZS; Xiao Y; Zhang QW; Li JQ
Bioorg Med Chem Lett; 2017 Dec; 27(24):5420-5423. PubMed ID: 29138029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
